Search research articles
Contact Us
Filters
Showing results (681-690 of 826) with videos related to
Page
of 83
Sort By:
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
September 14, 2020
Mechanistic insights on clearance and inhibition discordance between liver microsomes and hepatocytes when clearance in liver microsomes is higher than in hepatocytes
Christopher Keefer, George Chang, Anthony Carlo, et al.
Blood Cancer Journal
|
February 18, 2014
Activation of TAK1 by MYD88 L265P drives malignant B-cell Growth in non-Hodgkin lymphoma
S M Ansell, L S Hodge, F J Secreto, et al.
Leukemia & Lymphoma
|
October 15, 2020
Treatment facility volume and patient outcomes in Waldenstrom macroglobulinemia
Madugodaralalage D S K Gunaratne, Alexander J Sahakian, Jithma P Abeykoon, et al.
Hematological Oncology
|
June 11, 2016
FCGR3A/2A polymorphisms and diffuse large B-cell lymphoma outcome treated with immunochemotherapy: a meta-analysis on 1134 patients from two prospective cohorts
Hervé Ghesquières, Beth R Larrabee, Corinne Haioun, et al.
British Journal of Haematology
|
March 10, 2026
Family history of haematological malignancy and prognosis across non-Hodgkin lymphoma subtypes
George A Cholack, Raphael Mwangi, Prokop Vodička, et al.
British Journal of Haematology
|
May 30, 2018
Human Pegivirus infection and lymphoma risk and prognosis: a North American study
Angelo Fama, Jinhua Xiang, Brian K Link, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 17, 2020
Human Cancers Express TRAILshort, a Dominant Negative TRAIL Splice Variant, Which Impairs Immune Effector Cell Killing of Tumor Cells
Fatma Aboulnasr, Ashton Krogman, Rondell P Graham, et al.
Cancer Immunology, Immunotherapy : CII
|
July 2, 2013
CXCR5 polymorphisms in non-Hodgkin lymphoma risk and prognosis
Bridget Charbonneau, Alice H Wang, Matthew J Maurer, et al.
Health Policy (Amsterdam, Netherlands)
|
February 24, 2007
Comparison of mosquito control programs in seven urban sites in Africa, the Middle East, and the Americas
Daniel E Impoinvil, Sajjad Ahmad, Adriana Troyo, et al.
Journal of Affective Disorders
|
March 19, 2023
Patient preferences for key drivers and facilitators of adoption of mHealth technology to manage depression: A discrete choice experiment
S K Simblett, M Pennington, M Quaife, et al.
Page
of 83
Search research articles
Search
Showing results (681-690 of 826) with videos related to
Sort By:
Page
of 83
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
September 14, 2020
Mechanistic insights on clearance and inhibition discordance between liver microsomes and hepatocytes when clearance in liver microsomes is higher than in hepatocytes
Christopher Keefer, George Chang, Anthony Carlo, et al.
Blood Cancer Journal
|
February 18, 2014
Activation of TAK1 by MYD88 L265P drives malignant B-cell Growth in non-Hodgkin lymphoma
S M Ansell, L S Hodge, F J Secreto, et al.
Leukemia & Lymphoma
|
October 15, 2020
Treatment facility volume and patient outcomes in Waldenstrom macroglobulinemia
Madugodaralalage D S K Gunaratne, Alexander J Sahakian, Jithma P Abeykoon, et al.
Hematological Oncology
|
June 11, 2016
FCGR3A/2A polymorphisms and diffuse large B-cell lymphoma outcome treated with immunochemotherapy: a meta-analysis on 1134 patients from two prospective cohorts
Hervé Ghesquières, Beth R Larrabee, Corinne Haioun, et al.
British Journal of Haematology
|
March 10, 2026
Family history of haematological malignancy and prognosis across non-Hodgkin lymphoma subtypes
George A Cholack, Raphael Mwangi, Prokop Vodička, et al.
British Journal of Haematology
|
May 30, 2018
Human Pegivirus infection and lymphoma risk and prognosis: a North American study
Angelo Fama, Jinhua Xiang, Brian K Link, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 17, 2020
Human Cancers Express TRAILshort, a Dominant Negative TRAIL Splice Variant, Which Impairs Immune Effector Cell Killing of Tumor Cells
Fatma Aboulnasr, Ashton Krogman, Rondell P Graham, et al.
Cancer Immunology, Immunotherapy : CII
|
July 2, 2013
CXCR5 polymorphisms in non-Hodgkin lymphoma risk and prognosis
Bridget Charbonneau, Alice H Wang, Matthew J Maurer, et al.
Health Policy (Amsterdam, Netherlands)
|
February 24, 2007
Comparison of mosquito control programs in seven urban sites in Africa, the Middle East, and the Americas
Daniel E Impoinvil, Sajjad Ahmad, Adriana Troyo, et al.
Journal of Affective Disorders
|
March 19, 2023
Patient preferences for key drivers and facilitators of adoption of mHealth technology to manage depression: A discrete choice experiment
S K Simblett, M Pennington, M Quaife, et al.
Page
of 83